论文部分内容阅读
自身免疫性溶血是溶血性贫血最为常见的病因。温抗体型自身免疫性溶血性贫血(AIHA)占所有AIHA的80%左右,约70%对糖皮质激素治疗反应佳,但少部分患者疗效欠佳,且相当比例患者激素减量过程中病情易于复发。CD20单抗用于治疗滤泡型淋巴瘤、弥漫大细胞淋巴瘤等淋
Autoimmune hemolysis is the most common cause of hemolytic anemia. About 60% of all AIHA patients, about 70% of patients with AIHA respond well to glucocorticoid therapy, but less effective in a few patients, and a significant proportion of patients with Hormone-Reducing Hormone-Induced Hemolytic Anemia (AIHA) relapse. CD20 monoclonal antibody for the treatment of follicular lymphoma, diffuse large cell lymphoma and other leaching